The Role of Testosterone on Mediating Sex and Gender Influences on Chronic Orofacial Pain Conditions
睾酮在调节性别和性别对慢性口面部疼痛的影响中的作用
基本信息
- 批准号:10755148
- 负责人:
- 金额:$ 47.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-19 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAndrogen ReceptorAnimalsAnteriorAntiandrogen TherapyAttenuatedBehavioral ParadigmBiological AssayBrainBrain regionBurning Mouth SyndromeChronicClinicalCombined Modality TherapyDataDevelopmentDiseaseEvidence based treatmentFemaleFunctional Magnetic Resonance ImagingFunctional disorderGenderGeneticHigh PrevalenceHumanHypersensitivityIncidenceIndividualIrritable Bowel SyndromeKnowledgeLinkMeasuresMediatingMigraineModelingNeurobiologyNeuronsOrofacial PainOutcomePainPain DisorderPain MeasurementPain managementPlayPre-Clinical ModelPrevalencePropertyPsychophysicsRattusRestRiskRisk FactorsRoleSeveritiesSex DifferencesSystemTMD treatmentTemporomandibular Joint DisordersTestingTestosteroneTherapeuticVisceralWomanWorkantinociceptioncentral painchronic painful conditioncingulate cortexcisgenderclinical paincomorbidityconditioned pain modulationcraniofacialdiffuse noxious inhibitory controlevidence basegender differencegender transitiongenetic manipulationhormone therapyimprovedindexinginsightmalemenmidbrain central gray substanceneural circuitnovelpain inhibitionpain outcomepain processingpharmacologicpre-clinicalresponsescale upsextransgendertreatment responsetreatment strategy
项目摘要
ABSTRACT AND PROJECT SUMMARY
Many chronic pain conditions that affect craniofacial regions, such as temporomandibular disorders (TMD),
disproportionately affect females. A growing number of studies show strong evidence that sex-related differences
in conditioned pain modulation (CPM), a psychophysical index of endogenous pain inhibition, is one mechanism
that predisposes women to an increased risk of chronic pain conditions. However, the central mechanisms
underlying gender differences in CPM, as well as causal links between dysfunctional CPM and chronic orofacial
pain conditions, are largely unknown. Our prior work has shown that there are sex differences in descending
noxious inhibitory control (DNIC), a measure that is similar to CPM in preclinical settings, and that DNIC is
modulated in a testosterone (TS)-dependent manner. The efficiency of DNIC was stronger in males compared
to females. A pharmacological blockade of androgen receptors attenuated DNIC in males, and TS replacement
enhanced DNIC in female rats. We also provided compelling evidence that the efficient DNIC in males is
associated with a stronger resting functional connectivity between the rostral anterior cingulate cortex (rACC)
and the periaqueductal gray (PAG). These observations provide a strong rationale for investigating the impact
of TS on central pain modulation, and they also have significant clinical implications for pain management for
both transgender and cisgender individuals undergoing hormone therapy. In this project, we will investigate the
role of TS in maintaining efficient DNIC, as well as the mechanistic links between dysfunctional DNIC, TMD-like
pain, and TMD-related comorbid pain conditions. Specifically, we hypothesize that the rACC to PAG circuit
mediates sex differences in DNIC efficiency in a TS-dependent manner and that strengthening DNIC effectively
attenuates TMD-related primary and comorbid pain responses. In specific aim (SA) 1, we will determine the role
of the rACC to PAG circuit in DNIC efficiency using a behavioral paradigm and chemogenetics, which will
experimentally manipulate the strength of the circuit with and without anti-androgen treatment in males and with
and without TS treatment in females. In SA2, we will investigate the relationship between DNIC and TMD-like
pain responses. We will conduct a concurrent functional magnetic resonance imaging (fMRI) to assess pain-
induced changes in brain networks and confirm that both TS treatment and strengthening the rACC to PAG
circuit rectify the pain-induced changes in the brain networks in male and female rats. In SA3, we will determine
whether chemogenetically activating DNIC leads to a reduction in TMD-related comorbid pain responses and
whether TS treatment further enhances the chemogenetic effects. The project will significantly improve our
knowledge of the impact of sex on CNS pain modulation, which should have broad translational implications for
the development of customized therapeutic strategies for both transgender and cisgender individuals.
摘要和项目总结
许多影响颅面区域的慢性疼痛状况,如颞下颌关节紊乱病(TMD),
不成比例地影响女性。越来越多的研究表明,与性别有关的差异
在条件性疼痛调制(CPM),内源性疼痛抑制的心理物理指标,是一种机制
使女性患慢性疼痛的风险增加。然而,中央机制
CPM的潜在性别差异,以及CPM功能障碍和慢性口面之间的因果关系
疼痛状况,在很大程度上是未知的。我们之前的工作表明,下降存在性别差异
有害抑制控制(DNIC),一种类似于临床前环境中CPM的测量方法,并且DNIC是
以睾酮(TS)依赖性方式调节。DNIC的效率在男性中较强,
对女性来说。雄激素受体的药理学阻断可减弱男性的DNIC,TS替代
增强雌性大鼠的DNIC。我们还提供了令人信服的证据,证明男性的有效DNIC是
与喙侧前扣带皮层(rACC)之间更强的静息功能连接相关
和中脑导水管周围灰质(PAG)。这些观察结果为调查影响提供了强有力的理由
TS对中枢疼痛调节的作用,它们对疼痛管理也有重要的临床意义,
接受激素治疗的跨性别者和顺性别者。在这个项目中,我们将调查
TS在维持有效的DNIC中的作用,以及功能失调的DNIC、TMD样
疼痛和TMD相关的共病疼痛状况。具体地说,我们假设rACC到PAG回路
以TS依赖的方式介导DNIC效率的性别差异,
减弱TMD相关的原发性和共病性疼痛反应。在具体目标(SA)1中,我们将确定
使用行为范例和化学遗传学,研究了rACC至PAG回路在DNIC效率中的作用,
实验性地操纵回路的强度,在男性中有和没有抗雄激素治疗,
而在雌性中未进行TS治疗。在SA 2中,我们将研究DNIC和TMD样
疼痛反应我们将同时进行功能性磁共振成像(fMRI)来评估疼痛-
诱导脑网络的变化,并证实TS治疗和加强rACC到PAG
在雄性和雌性大鼠的大脑网络中,神经回路纠正了疼痛引起的变化。在SA 3中,我们将确定
化学发生激活DNIC是否导致TMD相关共病疼痛反应的减少,
TS处理是否进一步增强化学发生作用。该项目将大大改善我们的
了解性别对中枢神经系统疼痛调节的影响,这应该对以下方面具有广泛的翻译意义:
为变性人和顺性人制定定制的治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joyce Teixeira Da Silva其他文献
Joyce Teixeira Da Silva的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joyce Teixeira Da Silva', 18)}}的其他基金
相似海外基金
Androgen receptor: A master regulator of lipid metabolism
雄激素受体:脂质代谢的主要调节因子
- 批准号:
DP230103210 - 财政年份:2023
- 资助金额:
$ 47.14万 - 项目类别:
Discovery Projects
Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
通过蛋白质精氨酸甲基化调节前列腺癌中的雄激素受体信号传导
- 批准号:
10584689 - 财政年份:2023
- 资助金额:
$ 47.14万 - 项目类别:
Structural and functional analysis of a novel class of androgen receptor antagonists
一类新型雄激素受体拮抗剂的结构和功能分析
- 批准号:
10650956 - 财政年份:2023
- 资助金额:
$ 47.14万 - 项目类别:
Role of the Androgen Receptor in Insulin Secretion in the Male
雄激素受体在男性胰岛素分泌中的作用
- 批准号:
10488954 - 财政年份:2023
- 资助金额:
$ 47.14万 - 项目类别:
Targeting tumor cell macrophage lipid interactions to overcome resistance to androgen receptor targeted therapy
靶向肿瘤细胞巨噬细胞脂质相互作用以克服对雄激素受体靶向治疗的耐药性
- 批准号:
10651105 - 财政年份:2023
- 资助金额:
$ 47.14万 - 项目类别:
Preclinical development of ONCT-505, an Androgen Receptor Antagonist and Degrader, as new potential therapeutic for Kennedy's Disease
ONCT-505(一种雄激素受体拮抗剂和降解剂)的临床前开发,作为肯尼迪病的新潜在治疗方法
- 批准号:
10603636 - 财政年份:2023
- 资助金额:
$ 47.14万 - 项目类别:
Proliferating cell nuclear antigen in regulation of androgen receptor signalings in castration-resistant prostate cancer cells
增殖细胞核抗原对去势抵抗性前列腺癌细胞雄激素受体信号传导的调节
- 批准号:
10544062 - 财政年份:2022
- 资助金额:
$ 47.14万 - 项目类别:
Effects of androgen receptor (AR) signaling on CD4+ T cell metabolism during airway inflammation
气道炎症期间雄激素受体 (AR) 信号对 CD4 T 细胞代谢的影响
- 批准号:
10534943 - 财政年份:2022
- 资助金额:
$ 47.14万 - 项目类别:
TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE
标题:使用雄激素受体抑制剂阿帕鲁胺进行膀胱癌化学预防
- 批准号:
10677989 - 财政年份:2022
- 资助金额:
$ 47.14万 - 项目类别: